Literature DB >> 24664179

The nature of the control of blood glucose in those with poorer glucose tolerance influences mood and cognition.

Hayley Young1, David Benton.   

Abstract

The ability to control the levels of blood glucose was related to mood and cognition. 155 adults, aged 45-85 years, without a diagnosis of diabetes, were given an oral glucose tolerance test and cognitive tests. Participants were classified according to age (41-60/61-85 years), whether they had better or poorer glucose tolerance and whether blood glucose did or did not fall below baseline values. There were two main findings. Those with poorer glucose tolerance forgot more words and had slower decision times, but only if 61 years or older. Secondly as there are reports in animal studies that inducing low levels of blood glucose values benefited cognitive performance, for the first time in humans, individual differences in the tendency to develop low levels of blood glucose were considered. In those with poor glucose tolerance a tendency for blood glucose to fall below baseline values was associated with better mood and faster working memory.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664179     DOI: 10.1007/s11011-014-9519-2

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  35 in total

1.  Glucose tolerance predicts performance on tests of memory and cognition.

Authors:  R T Donohoe; D Benton
Journal:  Physiol Behav       Date:  2000 Nov 1-15

2.  Rate of peripheral glucose change during cognitive testing predicts performance in diabetes mellitus.

Authors:  Lawrence Charles Perlmuter; Parinda Haresh Shah; Brian Patrick Flanagan; Vijaya Surampudi; Yevgeniya Kosman; Sant Parkash Singh; Eshraq Al-Jaghbeer
Journal:  J Diabetes       Date:  2008-12-17       Impact factor: 4.006

3.  The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables.

Authors:  Peter Bright; Eli Jaldow; Michael D Kopelman
Journal:  J Int Neuropsychol Soc       Date:  2002-09       Impact factor: 2.892

Review 4.  Dynamics of insulin secretion in obesity and diabetes.

Authors:  K S Polonsky
Journal:  Int J Obes Relat Metab Disord       Date:  2000-06

5.  Auditory information processing during acute insulin-induced hypoglycaemia in non-diabetic human subjects.

Authors:  R J McCrimmon; I J Deary; B M Frier
Journal:  Neuropsychologia       Date:  1997-12       Impact factor: 3.139

6.  Pen-sized digital 30-second blood glucose meter.

Authors:  D R Matthews; R R Holman; E Bown; J Steemson; A Watson; S Hughes; D Scott
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

Review 7.  Cognition and diabetes: a lifespan perspective.

Authors:  Geert Jan Biessels; Ian J Deary; Christopher M Ryan
Journal:  Lancet Neurol       Date:  2008-02       Impact factor: 44.182

8.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

Authors:  P De Feo; V Gallai; G Mazzotta; G Crispino; E Torlone; G Perriello; M M Ventura; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 9.  Examining the mechanisms of glucose regulation.

Authors:  Curtis L Triplitt
Journal:  Am J Manag Care       Date:  2012-01       Impact factor: 2.229

10.  Postprandial reactive hypoglycaemia: varying presentation patterns on extended glucose tolerance tests and possible therapeutic approaches.

Authors:  Kevin Stuart; Annmarie Field; Jessie Raju; Sudarshan Ramachandran
Journal:  Case Rep Med       Date:  2013-01-10
View more
  1 in total

1.  Interoceptive accuracy moderates the response to a glucose load: a test of the predictive coding framework.

Authors:  Hayley A Young; Chantelle M Gaylor; Danielle de Kerckhove; Heather Watkins; David Benton
Journal:  Proc Biol Sci       Date:  2019-03-13       Impact factor: 5.349

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.